DOSEF
Price
$0.14
Change
-$0.36 (-72.00%)
Updated
Dec 3 closing price
SGMT
Price
$4.94
Change
-$0.03 (-0.60%)
Updated
Dec 24, 02:00 PM (EDT)
Ad is loading...

DOSEF vs SGMT

Header iconDOSEF vs SGMT Comparison
Open Charts DOSEF vs SGMTBanner chart's image
Doseology Sciences
Price$0.14
Change-$0.36 (-72.00%)
Volume$2K
CapitalizationN/A
Sagimet Biosciences
Price$4.94
Change-$0.03 (-0.60%)
Volume$4.64K
CapitalizationN/A
DOSEF vs SGMT Comparison Chart
Loading...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOSEF vs. SGMT commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and SGMT is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (DOSEF: $0.14 vs. SGMT: $4.97)
Brand notoriety: DOSEF and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 179% vs. SGMT: 48%
Market capitalization -- DOSEF: $488.77K vs. SGMT: $160.01M
DOSEF [@Biotechnology] is valued at $488.77K. SGMT’s [@Biotechnology] market capitalization is $160.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • DOSEF’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than DOSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOSEF’s TA Score shows that 4 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • DOSEF’s TA Score: 4 bullish, 4 bearish.
  • SGMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than SGMT.

Price Growth

DOSEF (@Biotechnology) experienced а 0.00% price change this week, while SGMT (@Biotechnology) price change was -13.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

Reported Earning Dates

SGMT is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($159M) has a higher market cap than DOSEF($490K). SGMT YTD gains are higher at: -8.303 vs. DOSEF (-37.277). DOSEF has higher annual earnings (EBITDA): -332.68K vs. SGMT (-45.73M). SGMT has more cash in the bank: 152M vs. DOSEF (990K). DOSEF has less debt than SGMT: DOSEF (0) vs SGMT (116K). DOSEF has higher revenues than SGMT: DOSEF (67K) vs SGMT (0).
DOSEFSGMTDOSEF / SGMT
Capitalization490K159M0%
EBITDA-332.68K-45.73M1%
Gain YTD-37.277-8.303449%
P/E RatioN/AN/A-
Revenue67K0-
Total Cash990K152M1%
Total Debt0116K-
TECHNICAL ANALYSIS
Technical Analysis
DOSEFSGMT
RSI
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 7 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFPAX10.330.04
+0.39%
Saratoga Financial Service A
FIQCX27.500.10
+0.36%
Fidelity Advisor Asset Manager 85% Z
RCGHX16.17N/A
N/A
Virtus KAR Health Sciences C
GCSIX27.91N/A
N/A
Goldman Sachs Small Cap Eq Insghts Instl
MFWGX16.18N/A
N/A
MFS Global Total Return R1

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
-7.05%
AKRO - DOSEF
23%
Poorly correlated
-3.31%
SGMT - DOSEF
21%
Poorly correlated
+0.40%
ADAG - DOSEF
21%
Poorly correlated
-8.29%
CLRPF - DOSEF
12%
Poorly correlated
N/A
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with ALLO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+0.40%
ALLO - SGMT
33%
Loosely correlated
+4.28%
CRSP - SGMT
33%
Poorly correlated
-0.59%
TRDA - SGMT
32%
Poorly correlated
-0.74%
PLRX - SGMT
30%
Poorly correlated
+0.98%
SLRN - SGMT
30%
Poorly correlated
+0.95%
More